◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › S › SYK

Stryker Corporation (SYK) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · Health Care Equipment · DATA UPDATED 2026-08-16

Stryker Corporation (SYK) operates in the Health Care Equipment industry and is headquartered in Portage, United States with about 56,000 employees. Its market capitalization is roughly $106 billion. In the fiscal year ended 2025-12-31, SYK reported $25.1B in revenue and $3.2B in net income.

Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics.

Interactive charts & full statements → Open the SYK valuation workbench →

SYK Revenue & Earnings History — Annual Income Statement

Income statement	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Revenue	$25.8B	$25.1B	$22.6B	$20.5B	$18.4B	$17.1B	$14.4B	$14.9B	$13.6B	$12.4B	$11.3B	$9.9B	$9.7B	$9.0B	$8.7B	$8.3B	$7.3B	$6.7B	$6.7B	$6.0B	$5.4B
Gross Profit	$16.8B	$16.1B	$14.0B	$12.5B	$11.0B	$10.7B	$8.8B	$9.4B	$8.6B	$7.9B	$7.2B	$6.4B	$6.2B	$5.9B	$5.8B	$5.5B	$5.0B	$4.5B	$4.5B	$4.1B	$3.5B
Gross Margin %	65.2%	64.0%	61.9%	61.0%	59.8%	62.6%	61.0%	63.0%	63.2%	63.5%	64.0%	64.2%	64.3%	65.9%	66.7%	66.4%	68.0%	67.0%	67.7%	68.2%	65.0%
Operating Income (EBIT)	$5.7B	$4.9B	$5.1B	$4.3B	$3.7B	$3.8B	$3.0B	$3.4B	$3.1B	$2.8B	$2.6B	$2.3B	$2.2B	$2.1B	$1.9B	$2.0B	$1.9B	$1.7B	$1.6B	$1.3B	$1.1B
Operating Margin %	22.0%	19.5%	22.4%	20.9%	20.2%	22.0%	21.1%	22.8%	22.8%	22.2%	22.8%	22.6%	23.0%	23.3%	22.1%	23.7%	25.3%	25.6%	23.1%	22.1%	20.8%
Net Income	$3.7B	$3.2B	$3.0B	$3.2B	$2.4B	$2.0B	$1.6B	$2.1B	$3.6B	$1.0B	$1.6B	$1.4B	$515M	$1.0B	$1.3B	$1.3B	$1.3B	$1.1B	$1.1B	$1.0B	$778M
Net Margin %	14.4%	12.9%	13.2%	15.4%	12.8%	11.7%	11.1%	14.0%	26.1%	8.2%	14.5%	14.5%	5.3%	11.2%	15.0%	16.2%	17.4%	16.5%	17.1%	17.0%	14.4%
EBITDA	$6.3B	$6.3B	$4.9B	$5.1B	$4.0B	$3.6B	$3.1B	$3.6B	$3.3B	$3.0B	$2.7B	$2.2B	$1.7B	$1.6B	$2.0B	$2.3B	$2.2B	$2.0B	$2.0B	$1.8B	$1.4B
Earnings Per Share (EPS)	$9.65	$8.49	$7.76	$8.25	$6.17	$5.22	$4.20	$5.48	$9.34	$2.68	$4.35	$3.78	$1.35	$2.63	$3.39	$3.45	$3.19	$2.77	$2.78	$2.44	$1.89
Shares Outstanding (M)	386M	382M	386M	384M	382M	382M	380M	380M	380M	380M	378M	381M	383M	382M	383M	390M	400M	399M	414M	417M	411M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

SYK Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Total Revenue	$6.6B	$6.0B	$7.2B	$6.1B	$6.0B	$5.9B	$6.4B	$5.5B
Gross Profit	$4.5B	$3.8B	$4.7B	$3.9B	$3.8B	$3.7B	$4.0B	$3.4B
Gross Margin %	68.3%	63.3%	65.2%	63.6%	62.3%	62.7%	62.0%	61.8%
Operating Income (EBIT)	$1.7B	$936M	$2.0B	$1.1B	$1.4B	$1.2B	$1.7B	$1.2B
Operating Margin %	25.2%	15.6%	27.4%	18.7%	22.6%	20.1%	25.8%	22.0%
Net Income	$1.3B	$745M	$849M	$859M	$884M	$654M	$546M	$834M
Net Margin %	19.4%	12.4%	11.8%	14.2%	14.7%	11.2%	8.5%	15.2%
EBITDA	$1.6B	$1.3B	$2.0B	$1.4B	$1.5B	$1.0B	$792M	$1.3B
Earnings Per Share (EPS)	$3.31	$1.93	$2.20	$2.22	$2.29	$1.69	$1.41	$2.16
Shares Outstanding (M)	386M	386M	386M	387M	386M	386M	386M	386M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

SYK Free Cash Flow History

Cash flow	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Cash from Operations (CFO)	$5.5B	$5.0B	$4.2B	$3.7B	$2.6B	$3.3B	$3.3B	$2.2B	$2.6B	$1.6B	$1.9B	$899M	$1.8B	$1.9B	$1.7B	$1.4B	$1.5B	$1.5B	$1.2B	$1.0B	$867M
Capital Expenditures (CapEx)	$823M	$761M	$755M	$575M	$588M	$525M	$487M	$649M	$572M	$598M	$490M	$270M	$233M	$195M	$210M	$226M	$182M	$131M	$155M	$188M	$218M
Free Cash Flow (FCF)	$4.7B	$4.3B	$3.5B	$3.1B	$2.0B	$2.7B	$2.8B	$1.5B	$2.0B	$961M	$1.4B	$629M	$1.5B	$1.7B	$1.4B	$1.2B	$1.4B	$1.3B	$1.0B	$841M	$650M
FCF Margin %	18.2%	17.1%	15.4%	15.3%	11.0%	16.0%	19.4%	10.4%	15.0%	7.7%	12.6%	6.3%	16.0%	18.8%	16.7%	14.5%	18.6%	19.8%	15.2%	14.0%	12.0%
Dividends Paid	$1.3B	$1.3B	$1.2B	$1.1B	$1.1B	$950M	$863M	$778M	$703M	$636M	$568M	$521M	$462M	$401M	$324M	$279M	$238M	$198M	$136M	$90M	$45M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

SYK Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Cash from Operations (CFO)	$1.3B	$581M	$2.1B	$1.5B	$1.1B	$250M	$1.9B	$1.5B
Capital Expenditures (CapEx)	$202M	$166M	$268M	$187M	$183M	$123M	$266M	$170M
Free Cash Flow (FCF)	$1.1B	$415M	$1.9B	$1.4B	$928M	$127M	$1.7B	$1.3B
FCF Margin %	16.1%	6.9%	26.2%	22.3%	15.4%	2.2%	25.9%	23.7%
Dividends Paid	$337M	$337M	$321M	$322M	$321M	$320M	$305M	$305M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

SYK Balance Sheet History

Balance sheet	2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Assets	$47.9B	$47.8B	$43.0B	$39.9B	$36.9B	$34.6B	$34.3B	$30.2B	$27.2B	$22.2B	$20.4B	$16.2B	$17.7B	$15.7B	$13.5B	$12.4B	$10.9B	$9.1B	$7.6B	$7.4B	$5.9B
Cash & Cash Equivalents	$3.4B	$4.0B	$3.7B	$3.0B	$1.8B	$2.9B	$2.9B	$4.3B	$3.6B	$2.5B	$3.3B	$3.4B	$1.8B	$1.3B	$1.4B	$905M	$1.8B	$659M	$701M	$290M	$417M
Total Liabilities	$23.9B	$25.4B	$22.3B	$21.3B	$20.3B	$19.8B	$21.2B	$17.4B	$15.5B	$12.2B	$10.9B	$7.7B	$9.1B	$6.7B	$4.9B	$4.7B	$3.7B	$2.5B	$2.2B	$2.0B	$1.7B
Total Debt (Short + Long-Term)	$14.9B	$16.0B	$13.6B	$13.1B	$13.2B	$12.5B	$14.0B	$11.1B	$9.9B	$7.2B	$6.9B	$4.0B	$4.0B	$2.8B	$1.8B	$1.8B	$1.0B	$18M	$20M	$17M	$15M
Total Shareholders' Equity	$24.0B	$22.4B	$20.6B	$18.6B	$16.6B	$14.9B	$13.1B	$12.8B	$11.7B	$10.0B	$9.6B	$8.5B	$8.6B	$9.0B	$8.6B	$7.7B	$7.2B	$6.6B	$5.4B	$5.4B	$4.2B

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive SYK viewer.

SYK Metric Deep Dives

Other Companies in Health Care Equipment

ABT · Abbott Laboratories — $178 billion
ISRG · Intuitive Surgical — $141 billion
MDT · Medtronic — $118 billion
BSX · Boston Scientific — $63 billion
EW · Edwards Lifesciences — $51 billion
BDX · Becton Dickinson — $49 billion
IDXX · Idexx Laboratories — $40 billion
DXCM · Dexcom — $34 billion

This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी

← SYFI All “S” companies SYLD →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.